BeOne Medicines AG
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2014 | $-8.7M | $-9.3M | $654.0K | $6.6M |
| FY2015 | $-39.8M | $-45.2M | $5.3M | $10.2M |
| FY2016 | $-89.5M | $-113.0M | $23.5M | $10.6M |
| FY2017 | $12.8M | $-33.6M | $46.4M | $42.9M |
| FY2018 | $-547.7M | $-618.0M | $70.3M | $87.1M |
| FY2019 | $-750.3M | $-839.9M | $89.6M | $134.2M |
| FY2020 | $-1.28B | $-1.40B | $117.5M | $183.5M |
| FY2021 | $-1.30B | $-1.56B | $262.9M | $240.7M |
| FY2022 | $-1.50B | $-1.82B | $325.4M | $303.2M |
| FY2023 | $-1.16B | $-1.72B | $561.9M | $367.6M |
| FY2024 | $-140.6M | $-633.3M | $492.7M | $441.6M |
| FY2025 | $1.13B | $941.7M | $185.8M | $510.9M |